Tuberculosis (TB) is a global public health problem especially in developing countries. Stop TB strategy is one of the intended goals of sustainable development goals 2015-2030 in Egypt.
Background
Tuberculosis (TB) is a global public health problem especially in developing countries. Stop TB strategy is one of the intended goals of sustainable development goals 2015-2030 in Egypt. Objective To declare the incidence and epidemiologic pattern of TB cases in the last 2 years and assess the validity of GeneXpert (GX) Mycobacterium tuberculosis/RIF resistance technique for rapid diagnosis of TB and rifampicin resistance.
Patients and methods
A prospective follow-up study was conducted to collect data from TB records from 1 January 2017 to 31 December 2018. In all, 452 clinically suspected TB cases underwent GX Mycobacterium tuberculosis/RIF resistance and standard culture on Löwenstein-Jensen medium for diagnosis of TB.
Results
By examining the 452 clinically suspected cases of TB, the diagnosis was confirmed in 123 (27.2%) cases with an incidence of 2.63/100 000 populations. The cases were 52% in the middle-age group (30-60 years), 78.9% were men. GX technique showed a sensitivity of 91.1% and specificity of 100% compared with Löwenstein-Jensen culture as a gold standard for diagnosis and showed rifampicin resistance in 12% of cases. Conclusion This incidence of TB in Menoufia Governorate is obviously lesser than the national figure which need more extended studies to declare if it is actual decline or just underreporting of cases. GX technique has a benefit of rapid testing and showed very good sensitivity that support its value for deciding early treatment beginning with its positive impact on disease transmissibility.
Introduction
Mycobacterium tuberculosis (MTB) infection causes tuberculosis (TB), one of the most serious problems in public health globally [1] . TB was one of the challenges included in sustainable development goals adopted by the United Nations. It aims at putting an end to the epidemics of TB worldwide [2].
Egypt is a middle/low TB burden country. Egyptian Ministry of Health and Population adopted the latest National Tuberculosis Control Program since September 2007 and showed progressive decrease in the incidence of TB from 21/100 000 populations in 2006 to 13/100 000 populations in 2017; TB prevention, diagnosis, and treatment saved 37 million lives [3] .
There are different diagnostic procedures for TB diagnosis; GeneXpert (GX) RIF resistance test represents a major milestone for TB diagnosis. It uses a sputum sample and can give a result in less than 2 h with specific accuracy in TB/HIV patients and it is a rapid detector of genetic mutations associated with resistance to the drug rifampicin [4, 5] .
Validity of GX MTB/RIF in many studies revealed a sensitivity of 100% and specificity of 75% [6] . Although there are many GX evaluation studies, the information is still limited in size and geographic representation and there are a few studies on GX evaluation in low-burden countries [7] .
This study aimed at measuring the incidence of TB in Menoufia Governorate and give spot on some epidemiological aspects of this infection along with assessing the diagnostic accuracy of GX MTB/RIF resistance test as a rapid test for TB and drug resistance.
Patients and methods

Patients
A prospective study was conducted to collect cases for ∼2 years from 1 January 2017 to 31 December 2018. The population is the attendants of outpatient clinic in Shebeen El Kom Chest Hospital (the reference hospital in Menoufia Governorate); 452 clinically suspected TB cases were enrolled in this 2-year survey.
Ethics statement
An approval from the research and Medical Ethics Committee in Faculty of Medicine, Menoufia University was obtained. An administrative approval was also obtained from the health directorate of Menoufia Governorate.
Available personal and clinical data of the patients were collected such as age, sex, and smoking status.
All TB suspected cases were subjected to specimen collection as follows:
Two sputum specimens were collected from each participant. They were asked to expectorate sputum and in case expectoration was not possible, induced sputum specimen was obtained by a well-trained nurse as previously described by Zar et al. [8] , or bronchoalveolar lavage (BAL) was performed via bronchoscope in patients unable to produce sputum to collect fluid. Depending on the symptoms, urine, cerebrospinal fluid (CSF) and other body fluids may be collected.
Sputum acid fast smear and culture on Löwenstein-Jensen medium were performed within 2 h at the hospital as routine procedures for TB diagnosis using standard techniques for mycobacterial laboratories [9] .
Sputum samples were also analyzed by GX (Cepheid, Sunnyvale, California, USA) following the manufacturer's instructions and aliquots were stored at 4°C for duplicate testing within 1 week, if needed. All GX results were read and interpreted separately from that of the clinical, culture, and radiological results in a blinded manner [10] .
Statistical analysis
The data were collected, tabulated, and analyzed by statistical package for the social sciences (SPSS) version 17.0 on IBM compatible computer (SPSS Inc., Chicago, Illinois, USA). Qualitative data were described as frequency and percentage and compared using χ 2 -testing while the quantitative one was presented as mean±SD and was compared using Student's t-test.
Results
A follow-up study was conducted over 2 years from 1 January 2017 to 31 December 2018 in the outpatient clinic in Chest Hospital, Menoufia Governorate; the clinically suspected TB patients were 452 patients.
Majority of the collected samples were sputum (94.9%); 2.2% was pleural fluid and 2.9% was CSF. All CSF samples were culture negative.
GX MTB/RIF testing predicted positive TB patients in 112 (24.8%) of suspected cases, 42 (9.3%) cases were invalid and the remaining were negative. GX test showed 13 (12%) patients with rifampicin resistance (Table 1) .
Cultivation on the LJ media (as a reference standards) showed that 123 (27.2%) suspected cases. Culture-positive cases showed that 91.1% of them were Xpert positive and the remaining 8.9% of them were Xpert negative while culture-negative cases showed that 12.8% of them were Xpert invalid and the remaining percentage were negative (Figure 1 ).
Assessing the validity of GX assay compared with the standard culture results showed a sensitivity of 91.1% and specificity of 100% with a total accuracy of 97.6% ( Table 2) .
The average estimate of the population of Menoufia Governorate in the mid-duration (January 2018) was 4 366 000 [11] . The chest hospital in Shebeen El-Kom city was the reference hospital in Menoufia for TB cases. The incidence of TB in Menoufia was 2.63/100 000 populations ( Table 3 ).
The age of confirmed TB cases was 49.69±15.31 years with 61.8% in the productive age (30-60) and 78.9% were men. They were mainly smokers (56.1%) and retreatment cases were eight (6.5%) cases of confirmed TB cases (Table 1 ).
Discussion
In this study, the estimated incidence of pulmonary TB was 2.63/100 000 populations. This incidence is much lesser than the incidence of TB in Menoufia Governorate documented by Elwahsh et al. [12] , which were 5.1/100 000 populations. The noted incidence was also significantly lower than the documented Egyptian incidence reported in WHO Egypt TB profile which was 13/100 000 populations in the total population and 11/100 000 populations in population older than 14 years which coincide with the character of our population [3] . WHO Global Tuberculosis Report, 2018 provided an interpretation for such difference as a mixture of underreporting of detected cases and underdiagnosis (either because people do not access healthcare or because they are not diagnosed when they do). Also to the best of our knowledge, there is lack in distributed incidence of TB in different country regions to assess if there are hot zones in need for intensive interest which we recommend for future work [13] .
This results showed that 61.8% of the studied TB patients was in the active productive age (30-60) and 78.9% were men. These results were supported by a study in the same region which stated that 53.8% of pulmonary TB cases was found in middle-aged persons (25-54 years) and 68.3% were men [12] and Sobh et al. [14] (another Egyptian study) found similar results in Aswan, Egypt.
Smoking has been shown to significantly associate with confirmed TB cases (56.1%); this result is in line with Naini et al. [15] , who documented a smoking risk for developing TB as 3.1.
In this study, the sensitivity of GX testing was 91.1% and specificity 100% with total accuracy of this technique (97.6%). These results are in agreement with Moussa et al. [16] , who found that the sensitivity and specificity of the GX assay were 93 and 98.3%, respectively, while Meawed and Shaker [17] stated that GX MTB/RIF showed a sensitivity, specificity, and an accuracy of 98.15, 75 and 96.55%, respectively; the total accuracy is close but it showed much lesser specificity. Regarding rifampicin resistance, the test showed 12% rifampicin resistance among the TB confirmed cases. Moussa et al. [16] reported that no RIF resistance cases were detected. Egyptian results were much lesser than that detected in India by Sharma et al. [18] , which was 56.3%. This may be due to that India is one of high TB burden countries while Egypt is one of middle/low TB burden countries, so the RIF resistance is higher in India [13] .
Conclusion TB as a global public health problem is still a challenge in multiple areas in the world. Our area accounted for a much lesser incidence than the national figure that may reflect either actual low level of TB incidence in our area or underdiagnosis/underreporting of the cases for more future in deep studies. GX RIF resistance assay is a sensitive method for TB diagnosis and RIF resistance detection for rapid treatment beginning till culture results appear to help in eliminating the case as an epidemiologic source of infection.
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